O fio das notícias do Brasil

Receba as notícias no WhatsApp

Anvisa orders recall of weight-loss pen ingredients from distributor

Agency ordered the recall of one batch of tirzepatide and all batches of retatrutide stored at Condor, due to a storage failure.

Por O Fio

This is a translation of the original article in Portuguese. Read the original (Português).

Brazil’s Health Regulatory Agency (Anvisa) ordered the recall of one batch of active pharmaceutical ingredient (API) tirzepatide and of all batches of retatrutide stored at the distributor Condor Importador & Operador Logístico Ltda. The measure was published in the Diário Oficial da União, the official gazette, on Thursday (12), according to the Brazilian newspaper Diário da Manhã.

According to the agency, the site where the ingredients were kept did not have the infrastructure needed to store this type of product properly. Anvisa also said that retatrutide is not registered in Brazil.

An active pharmaceutical ingredient is the substance used as the base for manufacturing medicines, including compounded drugs. A registered medicine has been evaluated by the agency, which examines its quality, safety and efficacy. A substance without registration, such as retatrutide, has no such approval to be sold in the country. When it is stored outside the required conditions, as in the case flagged by Anvisa, the product’s quality can be compromised.

The issue carries weight because so-called weight-loss pens have moved beyond a niche and become a mass consumer product. As demand rises, the parallel market and compounding have also grown, and consumers do not always know where the substance injected into their bodies comes from.

For people who use or are considering this type of product, the agency’s decision is a reminder that origin matters. A poorly stored or unregistered ingredient poses a direct health risk. Consumers should be wary of informal offers and check whether the product is registered with Anvisa and comes from a licensed establishment.

The text published in the Diário Oficial addresses the recall of the items kept at the distributor. The measure covers the tirzepatide batch and all retatrutide batches that were under the company’s custody.

Reporting from Diário da Manhã (p. 6, caderno nacional: Anvisa manda recolher lotes de insumos para canetas emagrecedoras).

Esta matéria reúne informações publicadas pelos veículos citados acima, com edição da redação do O Fio. Conheça nossa política editorial. Encontrou um erro? Fale com a redação.

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

Os comentários passam por moderação antes de aparecer. Seu e-mail não é publicado. Ofensas, ataques pessoais e propaganda são removidos. Veja a política de privacidade.